ArticleBMC cancer2011

Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.

Bernard Krust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.